Viewing Study NCT07374003


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 1:11 AM
Study NCT ID: NCT07374003
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2026-01-28
First Post: 2025-12-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ipromlimab and Tuvonralimab Combined With Albumin-Bound Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module